Quick Takeaways
- Octagon Capital Advisors LP filed SCHEDULE 13G/A for Taysha Gene Therapies, Inc. Common Stock, $0.00001 par value (TSHA).
- Disclosed ownership: 3.3%.
- Date of event: 30 Sep 2025.
Octagon Capital Advisors LP - 30 Sep 2025 SCHEDULE 13G/A Report for Taysha Gene Therapies, Inc. Common Stock, $0.00001 par value (TSHA)
- Filing Manager
- Octagon Capital Advisors LP
- Reporting Manager
- Octagon Capital Advisors LP
- Symbol
- TSHA
- Shares outstanding
- 274,772,727 shares
- Disclosed Ownership
- 9,067,500 shares
- Ownership
- 3.3%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Nov 2025, 16:46:07 UTC
- Date of event
- 30 Sep 2025
- Previous filing
- 05 Feb 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Octagon Capital Advisors LP disclosed 3.3% ownership in Taysha Gene Therapies, Inc. Common Stock, $0.00001 par value (TSHA) on 30 Sep 2025."
What Changed
- Previous schedule filing date: 05 Feb 2025.
- Current filing was accepted on 14 Nov 2025, 16:46.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Octagon Capital Advisors LP | 3.3% | 9,067,500 | 0 | 9,067,500 | /s/ Ting Jia | Managing Member | |
| Octagon Investments Master Fund | 3.3% | 9,067,500 | 0 | 9,067,500 | /s/ Ting Jia | Managing Member, Octagon Investments GP, LLC, its general partner | |
| Ting Jia | 3.3% | 9,067,500 | 0 | 9,067,500 | /s/ Ting Jia | Ting Jia |